<DOC>
	<DOCNO>NCT02183818</DOCNO>
	<brief_summary>We aim use integrated network system approach analyze certain exist small airway epithelium ( SAE ) omic data set genetic , epigenetic ( methylation ) , gene expression , microRNA metabolomic level , develop initial model network connectivity key network pressure point relevant SAE biology health disease .</brief_summary>
	<brief_title>Integrative-omics Disordered COPD Small Airway Epithelium</brief_title>
	<detailed_description>Hypothesis : We hypothesize disordered differentiation SAE characterize COPD result complex interaction cigarette smoke component hierarchy genetic , epigenetic , gene expression metabolomics network interaction BC differentiate mucociliary epithelium . Specific aim 1 . Using integrated network system approach analyze extensive exist SAE omic data set genetic , epigenetic ( methylation ) , gene expression , microRNA metabolomics level , develop initial model network connectivity key network pressure point relevant SAE biology health disease . Specific aim 2 . To refine model , comprehensive omics data set collect multiple time point SAE BC nonsmoker COPD smoker differentiate normal disordered mucociliary epithelium ( respectively ) air-liquid interface ( ALI ) culture , vitro model SAE differentiation . The computational strategy aim 1 use improve model data . Specific aim 3 . To test finalize integrate network model , parallel omics data set generate BC nonsmoker , COPD smoker differentiate ALI condition key hubs up- down-regulated differentiation process stress condition mimic vivo SAE environment . The end result integrate system model SAE biology disorder COPD .</detailed_description>
	<criteria>Healthy nonsmoker ( n=50 ) Inclusion criterion Must enrol IRB approve protocol # 1204012331 ( inclusion criterion protocol # 1204012331 thus applies protocol ) Selfreported neversmokers , current smoking status validate absence nicotine metabolite urine ( nicotine less 2 ng/ml cotinine le 5 ng/ml ) Negative HIV serology Smokers COPD ( n=50 ) Inclusion criterion Must enrol IRB approve protocol # 1204012331 ( inclusion criterion protocol # 1204012331 thus applies protocol ) Selfreported current daily smoker great equal 10 packyr , validate following : urine nicotine great 30 ng/ml urine cotinine great 50 ng/ml Meeting GOLD stag IIII criterion chronic obstructive lung disease ( COPD ) base postbronchodilator spirometry Taking pulmonaryrelated medication , include betaagonists , anticholinergic , inhaled corticosteroid Negative HIV serology Healthy nonsmoker ( n=50 ) Exclusion criterion Unable meet inclusion criterion ( exclusion criterion protocol # 1204012331 applies protocol ) Evidence malignancy within past 5 year Smokers COPD ( n=50 ) Exclusion criterion Unable meet inclusion criterion ( exclusion criterion protocol # 1204012331 applies protocol ) Individuals participation study would compromise normal care expect progression disease Evidence malignancy within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Smoking</keyword>
	<keyword>COPD</keyword>
	<keyword>Non-Smokers</keyword>
	<keyword>Smokers</keyword>
</DOC>